MIR7108: A Potential Drug Target and Biomarker for Cancer (G102466806)
MIR7108: A Potential Drug Target and Biomarker for Cancer
MIR7108 (hsa-miR-7108-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and various studies have demonstrated its potential in preclinical models.
MIR7108 is a microRNA (miRNA) molecule that is expressed in various tissues and cells throughout the body. It is characterized by its length, which is approximately 200 nucleotides, and its highly conserved structure. MIR7108 has been shown to play a role in various biological processes, including cell growth, apoptosis, and inflammation.
One of the reasons why MIR7108 has been identified as a potential drug target is its expression pattern in cancer cells. Cancer is a disease that affects various tissues and organs in the body and is characterized by the rapid growth and uncontrolled cell division of cells. MIR7108 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer.
In addition to its expression in cancer cells, MIR7108 has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. MIR7108 has been shown to promote apoptosis in cancer cells, which may contribute to their sensitivity to chemotherapy and other treatments.
Another potential drug target for MIR7108 is its role in inflammation. Chronic inflammation is a major risk factor for various diseases, including cardiovascular disease and chronic obstructive pulmonary disease (COPD). MIR7108 has been shown to be involved in the regulation of inflammation and has been shown to play a role in the development of various inflammatory diseases.
In addition to its potential as a drug target and biomarker, MIR7108 has also been shown to have potential therapeutic applications in various diseases. For example, MIR7108 has been shown to be downregulated in various diseases, including cancer, and may be a potential therapeutic target to activate its expression. Additionally, MIR7108 has been shown to have potential as a biomarker for various diseases, including cancer, which may be used to monitor disease progression and treatment effectiveness.
In conclusion, MIR7108 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and various studies have demonstrated its potential in preclinical models. Further research is needed to fully understand the role of MIR7108 in diseases and to develop safe and effective therapies based on its properties.
Protein Name: MicroRNA 7108
The "MIR7108 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7108 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2
